SMS Pharmaceuticals · NSE: SMSPHARMA · BSE: 532815
Q3 FY19 results · Oct–Dec 2018
SMS Pharmaceuticals reported revenue from operations of ₹101.25 crore and net profit of ₹12.19 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 101.25 | — | — | 134.84 | −24.9% |
| Other income | 0.59 | — | — | 1.49 | −60.1% |
| Total income | 101.85 | — | — | 136.33 | −25.3% |
| Profit before tax | 18.64 | — | — | 19.04 | −2.1% |
| Net profit for the period | 12.19 | — | — | 12.56 | −2.9% |
| EPS, basic (₹) | 1.44 | — | — | 1.48 | −2.7% |
| Net margin (%) | 12.0 | — | 9.3 |
Standalone
- Filed with BSE
- 16 Feb 2019, 11:10 IST
- Board meeting
- 14 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE